VALIDATED EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
60
PAGES
205
EDITION
7
PRICE
USD $4950

Healthcare reforms and the ensuing migration to value based care will provide the Launchpad for increased acceptance, adoption and proliferation of DTx, as the technology has the potential to reduce healthcare costs while simultaneously increase efficiency. Key features that make DTx a natural fit for value based care include cost of DTx which is significantly lower than traditional medicine; patient centric continuum of care; use of outcome oriented and evidence based therapeutic solutions; elimination of wasteful healthcare expenditure as timely care reduces the need for diagnostic and intensive drug interventions; lower consumption of hospital resources as it reduces the pressure on an already overburdened emergence care; better use of patient engagement that encourages self-management of diseases; and use of real-time actionable insights that help optimize care delivery decisions. Digital solutions which are emerging as effective therapy tools include electronic CBT (cognitive behavioral therapy); virtual therapy guidance and counselling that include web therapy, phone therapy, text therapy or online therapy; therapy support applications that educate and offer advice on coping strategies, relaxation techniques, medication reminders and references to nearby treatment programs to ensure accessibility; and telediagnosis/remote diagnostics. Of special note is the hidden and the yet untapped value in the "Medicine as a Service" business model that brings even pharmaceutical companies into the value based care loop. Faced with competition and profitability pressures, drug companies are entering into the DTx space as powerful ecosystem players backed with financial resources to offer services that improve access and adherence to prescription drugs for chronic conditions. Powered by the dynamics of cloud computing "Medicine as a Service" pushes patients into the center of business strategies of drug companies.
As the healthcare community seeks to cost-effectively tackle the growing economic and financial burden of chronic diseases such as diabetes, hypertension and cardiovascular diseases, DTx will emerge as the way forward in healthcare. As the number of people living with diseases increase, healthcare strategies should evolve beyond just the pill to a continuous care plan that include staying informed and engaged. The biggest impact of DTx is in the field of mental health as it offers a novel therapy platform for this hugely unmet medical field. Gamification in mental health apps is the newest mhealth tool for positive behavioral reinforcement and to promote patient engagement. Telepsychiatry using videoconferencing and telemedicine eliminates the stigma associated with psychiatric care by offering patients discreet ways to receive medication management care and timely psychiatric evaluations. The United States and Europe represent large markets worldwide with a combined share of 84.4% of the global market. The United States also ranks as the fastest growing market with a CAGR of 27.8% over the analysis period supported by well-developed digital infrastructure that provides the foundation for DTx. The country also spearheads the global commitment towards value-based care and outcome-based healthcare with robust financial incentives that encourage value-based care and disincentives that penalize and prevent wasteful healthcare spending among hospitals.
INSIDER ACCESS PRIVILEGES
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Digital Therapeutics: An Introduction |
Outlook |
Leading Markets |
Factors Impeding Growth |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
Canary Health, Inc. (USA) |
Dthera Sciences (USA) |
Fitbit Health Solutions (USA |
Livongo Health, Inc. (USA) |
Medtronic, Plc (Ireland) |
Omada Health, Inc. (USA) |
Propeller Health (USA) |
Pear Therapeutics, Inc. (USA) |
Proteus Digital Health, Inc. (USA) |
WellDoc, Inc. (USA) |
3. MARKET TRENDS & DRIVERS |
Digital Therapeutics Continue to Attract Venture Capital Investments |
TABLE: Total Venture Capital Funding and Number of Deals in Digital Health Space: 2011-2018 |
TABLE: Digital Health Funding by Segment (in US$ Million): 9M 2019 |
Startups Flock the Digital Therapeutics Market |
Select Digital Therapeutics Startups |
Digital Health Unicorn Startups |
Table: Quarterly Investments by Digital Therapeutics Startups in US$ Million: Q1 2018 to Q2 2019 |
Pipeline Products Drive Growth Prospects |
A Snapshot of Select DTx Pipeline Products |
Pharma Majors Foray into Uncharted Territory |
Pharmaceutical Companies Team Up with Payers to Seek Reimbursement |
Growing Focus on Preventative Healthcare Widens Growth Opportunities |
Overcoming the Stigma of Mental Health through Digital Therapeutics |
Global Number of People Suffering from Mental Disorders (In Million) |
Growing Prevalence of Chronic Diseases to Boost Market Growth |
TABLE: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 |
TABLE: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) |
Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 |
Digital Therpeutics in Oncology |
Proliferation of Smart Devices Bodes Well for Market Growth |
TABLE: Smartphone Penetration (as a Proportion of Total Mobile Users) by Region for the Years 2018 and 2025 |
TABLE: United States Mobile Health Apps Market by Type (in %): 2018 & 2025 |
Growing Focus on Reducing Healthcare Costs Bolsters Market Growth |
TABLE: Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022 |
Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver |
TABLE: Global Population for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
4. GLOBAL MARKET PERSPECTIVE |
Digital Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
Digital Therapeutics Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 |
Preventive (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027 |
Preventive (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027 |
Treatment/Care (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 |
Treatment/Care (Application) Market Share Shift across Key Geographies: 2020 VS 2027 |
B2C (Sales Channel) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 |
B2C (Sales Channel) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
B2B (Sales Channel) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027 |
B2B (Sales Channel) Market Share Breakdown by Region/Country: 2020 VS 2027 |
III. MARKET ANALYSIS |
GEOGRAPHIC MARKET ANALYSIS |
UNITED STATES |
United States Digital Therapeutics Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 |
Digital Therapeutics Market Share Breakdown in the United States by Application: 2020 VS 2027 |
United States Digital Therapeutics Market Estimates and Projections in US$ Thousand by Sales Channel: 2020 to 2027 |
United States Digital Therapeutics Market Share Breakdown by Sales Channel: 2020 VS 2027 |
CANADA |
Canadian Digital Therapeutics Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 |
Canadian Digital Therapeutics Market Share Analysis by Application: 2020 VS 2027 |
Canadian Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2020 to 2027 |
Digital Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Sales Channel for 2020 and 2027 |
JAPAN |
Japanese Demand Estimates and Forecasts for Digital Therapeutics in US$ Thousand by Application: 2020 to 2027 |
Digital Therapeutics Market Share Shift in Japan by Application: 2020 VS 2027 |
Japanese Market for Digital Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Sales Channel for the Period 2020-2027 |
Japanese Digital Therapeutics Market Share Analysis by Sales Channel: 2020 VS 2027 |
CHINA |
Chinese Demand for Digital Therapeutics in US$ Thousand by Application: 2020 to 2027 |
Chinese Digital Therapeutics Market Share Breakdown by Application: 2020 VS 2027 |
Chinese Digital Therapeutics Market Growth Prospects in US$ Thousand by Sales Channel for the Period 2020-2027 |
Chinese Digital Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2020 and 2027 |
EUROPE |
European Digital Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
European Digital Therapeutics Market Share Shift by Region/Country: 2020 VS 2027 |
European Digital Therapeutics Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 |
European Digital Therapeutics Market Share Analysis by Application: 2020 VS 2027 |
European Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2020-2027 |
European Digital Therapeutics Market Share Breakdown by Sales Channel: 2020 VS 2027 |
FRANCE |
Digital Therapeutics Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027 |
French Digital Therapeutics Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027 |
Digital Therapeutics Market in France by Sales Channel: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
French Digital Therapeutics Market Share Analysis by Sales Channel: 2020 VS 2027 |
GERMANY |
Digital Therapeutics Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 |
Digital Therapeutics Market Share Distribution in Germany by Application: 2020 VS 2027 |
Digital Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Sales Channel for the Period 2020-2027 |
German Digital Therapeutics Market Share Breakdown by Sales Channel: 2020 VS 2027 |
ITALY |
Italian Demand for Digital Therapeutics in US$ Thousand by Application: 2020 to 2027 |
Italian Digital Therapeutics Market Share Breakdown by Application: 2020 VS 2027 |
Italian Digital Therapeutics Market Growth Prospects in US$ Thousand by Sales Channel for the Period 2020-2027 |
Italian Digital Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2020 and 2027 |
UNITED KINGDOM |
United Kingdom Demand Estimates and Forecasts for Digital Therapeutics in US$ Thousand by Application: 2020 to 2027 |
Digital Therapeutics Market Share Shift in the United Kingdom by Application: 2020 VS 2027 |
United Kingdom Market for Digital Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Sales Channel for the Period 2020-2027 |
United Kingdom Digital Therapeutics Market Share Analysis by Sales Channel: 2020 VS 2027 |
REST OF EUROPE |
Rest of Europe Digital Therapeutics Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 |
Rest of Europe Digital Therapeutics Market Share Analysis by Application: 2020 VS 2027 |
Rest of Europe Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2020-2027 |
Rest of Europe Digital Therapeutics Market Share Breakdown by Sales Channel: 2020 VS 2027 |
ASIA-PACIFIC |
Digital Therapeutics Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027 |
Asia-Pacific Digital Therapeutics Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027 |
Digital Therapeutics Market in Asia-Pacific by Sales Channel: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
Asia-Pacific Digital Therapeutics Market Share Analysis by Sales Channel: 2020 VS 2027 |
REST OF WORLD |
Rest of World Digital Therapeutics Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 |
Rest of World Digital Therapeutics Market Share Analysis by Application: 2020 VS 2027 |
Rest of World Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2020 to 2027 |
Digital Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Sales Channel for 2020 and 2027 |
IV. COMPETITION |
Total Companies Profiled : 56 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com